1. From the Divisions of Medical Oncology and Biometrics, Netherlands Cancer Institute; CLB, Sanquin Blood Supply Foundation, Laboratory for Experimental and Clinical Immunology, and Department of Hematology, Academic Medical Center, University of Amsterdam; and Department of Medical Oncology, Division of Gene Therapy Program, University Hospital of Vrije Universiteit, Amsterdam, Netherlands.